Presentation CIT 2013 New Clinical Indications…TAVR in Moderate Risk Patients: Experiences and Studies Presenter: Martin B. Leon March 22, 2013 REGISTER for free or LOG IN to view this content Aortic Valve Presentation CIT 2013 Up Next Presentation EuroPCR 2013 First-in-man study of dedicated bifurcation sirolimus-eluting stent BiOSS LIM® – complete 6-month clinical results Presenter: Robert J. Gil May 22, 2013 More slides + Presentation EuroPCR 2013 PEPCAD China ISR Presenter: Run-Lin Gao May 23, 2013 Presentation 3-Center Comparison of 1-Year Mortality Between TAVR and Surgery on the Basis of Propensity Score Matching Among Intermediate-Risk Surgical Patients Presenter: N. Piazza May 20, 2013 We Recommend
Presentation EuroPCR 2013 First-in-man study of dedicated bifurcation sirolimus-eluting stent BiOSS LIM® – complete 6-month clinical results Presenter: Robert J. Gil May 22, 2013
Presentation 3-Center Comparison of 1-Year Mortality Between TAVR and Surgery on the Basis of Propensity Score Matching Among Intermediate-Risk Surgical Patients Presenter: N. Piazza May 20, 2013